Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Squamous Cell 8Lung Neoplasms 7Leukemia, Myeloid, Acute 7Glioblastoma 7Colorectal Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Recurrence 5Pancreatic Neoplasms 5Melanoma 5Leukemia 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Rectal Neoplasms 3Lymphoma, Follicular 3Colonic Neoplasms 3Brain Neoplasms 3Treatment 2Sarcoma 2Pleural Effusion, Malignant 2Pharyngeal Neoplasms 2

Interventions

Dexamethasone 43Cyclophosphamide 38fludarabine phosphate 27Cytarabine 26Rituximab 24Methotrexate 21Lenalidomide 21Bortezomib 21Calcium Dobesilate 20fludarabine 19Peripheral Blood Stem Cell Transplantation 19Whole-Body Irradiation 16Mycophenolic Acid 16pembrolizumab 15Gemcitabine 15Etoposide 15pomalidomide 14Melphalan 14Vincristine 13Filgrastim 13Busulfan 13Tacrolimus 12Cyclosporine 12Carboplatin 12Paclitaxel 11carfilzomib 10durvalumab 9Doxorubicin 9Cetuximab 9Brentuximab Vedotin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Recurrence × Drug Therapy × Clear all
NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
289 enrolled 32 charts 1 FDA

Recurrence

NCT03257267 2025-04-08

Study of Cemiplimab in Adults With Cervical Cancer

Regeneron Pharmaceuticals

Phase 3 Completed
608 enrolled 18 charts

Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

NCT05718466 2023-07-17

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Henry Ford Health System

Phase 3 Completed
35 enrolled 13 charts
CNS

Glioblastoma, Recurrence

NCT02855944 2023-06-09

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

pharmaand GmbH

Phase 3 Completed
349 enrolled 29 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01841021 2017-01-19

Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
1 enrolled 5 charts
Lymphoid

Recurrence, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡